Reversing aging-induced lymphatic dysfunction to improve immune function

逆转衰老引起的淋巴功能障碍,改善免疫功能

基本信息

  • 批准号:
    10371505
  • 负责人:
  • 金额:
    $ 24.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

One significant problem with aging is a reduced ability to generate immune responses to bacterial, viral and fungal infections, leading to more hospitalizations and putting elderly people at greater risk of death from common infections. This problem has been starkly demonstrated by the greater rates of hospitalization and death from SARS-CoV-2 infections in older people. Older people also have lower rates of generating immunity after vaccination, leaving them vulnerable to common infectious diseases. Thus, there is a need to improve the function of the immune system in elderly people in order to lower rates of infections and their associated burdens. The lymphatic system—consisting of lymph nodes and lymphatic vessels—plays a central role in generating immune responses, which depend on lymph flow to carry antigens from the pathogen to lymph nodes to activate immune cells. We, and others, have shown that lymphatic function and lymph flow are reduced in aged animals. The reduced lymph flow limits antigens from getting to lymph nodes and initiating an immune response. Thus, poor lymphatic function can be one potential factor that contributes to reduced immune function in the elderly. The mechanisms behind reduced lymphatic function in aged mice are not well characterized. Further, there are no FDA approved drugs indicated to improve lymphatic function. The overall goal of the proposed project is to define the mechanisms that drive the aging-related reduction in lymphatic function in order to target these mechanisms to boost both lymphatic and immune function in aged mice. Lymphatic muscle cells (LMCs) are a natural target cell to boost lymphatic function as they drive lymph flow by causing rapid lymphatic vessel contractions. LMCs however have not been well characterized and are often considered vascular smooth muscle cells, despite clear phenotypic differences in the behavior of these cell types. Building on our recently generated transcriptome of LMCs, we will compare the transcriptomes of LMCs from freshly isolated collecting lymphatic vessels from young and old mice in the proposed work. These data will identify mechanistic pathways to target in order to boost lymphatic function in aged animals. Further, we will determine whether the transcriptional changes are dictated by age-related microenvironmental differences. We will also test the causal relationship between poor immune function and poor lymphatic function in aged mice by increasing lymphatic pumping pharmacologically. Long-term, we will validate our findings in human tissue and develop therapeutic approaches to boost lymphatic function in elderly people. This work will form the basis for the first FDA approved drugs to improve lymphatic function. Our novel therapeutic concept would lead to fewer hospitalizations and deaths due to infections in elderly people as well as better vaccine efficacy, which will prevent common viruses, such as influenza or SARS-CoV-2, from driving mortality in elderly people. This work will be carried out by a world-class team of experts in lymphatic vessel biology, immunology, single cell RNAseq data analysis, intravital lymph flow measurements and clinical care of patients with lymphatic diseases.
衰老的一个重要问题是对细菌、病毒和 真菌感染导致更多的住院治疗,并使老年人面临更大的死于常见疾病的风险 感染。这一问题已经从更高的住院率和死亡率上得到了鲜明的证明。 SARS-CoV-2在老年人中的感染。老年人在死后产生免疫力的比率也较低 接种疫苗,使他们容易感染常见的传染病。因此,有必要改进 老年人免疫系统的功能,以降低感染率及其相关 负担。淋巴系统--由淋巴结和淋巴管组成--在 产生免疫反应,依靠淋巴流动将抗原从病原体带到淋巴结 来激活免疫细胞。我们和其他人已经证明,淋巴功能和淋巴流量在 年迈的动物。淋巴流量的减少限制了抗原进入淋巴结并启动免疫。 回应。因此,淋巴功能低下可能是导致免疫功能下降的一个潜在因素。 在老年人身上。老年小鼠淋巴功能降低的机制还没有得到很好的描述。 此外,没有FDA批准的药物表明可以改善淋巴功能。该计划的总体目标 拟议的项目是定义驱动与衰老相关的淋巴减少的机制 为了针对这些机制,提高老龄小鼠的淋巴和免疫功能。 淋巴肌肉细胞(LMC)是促进淋巴功能的天然靶细胞,因为它们通过 导致淋巴管快速收缩。然而,LMC还没有得到很好的表征,而且经常 被认为是血管平滑肌细胞,尽管这些细胞类型的行为有明显的表型差异。 在我们最近生成的LMC转录组的基础上,我们将比较来自 在拟议的工作中,新分离的收集幼年和老年小鼠的淋巴管。这些数据将 确定靶向的机械途径,以提高老年动物的淋巴功能。此外,我们还将 确定转录变化是否由年龄相关的微环境差异决定。我们 还将通过以下方式测试老年小鼠免疫功能低下和淋巴功能低下之间的因果关系 增加淋巴泵的药理作用。从长远来看,我们将在人体组织中验证我们的发现 开发提高老年人淋巴功能的治疗方法。这项工作将构成以下内容的基础 FDA第一次批准了改善淋巴功能的药物。我们的新治疗概念将导致更少 老年人因感染而住院和死亡,以及更好的疫苗效力,这将 防止常见病毒,如流感或SARS-CoV-2,导致老年人死亡。这部作品 将由世界一流的淋巴管生物学、免疫学、单细胞RNAseq专家团队进行 淋巴疾病患者的数据分析、活体淋巴流量测量和临床护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TIMOTHY P PADERA其他文献

TIMOTHY P PADERA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TIMOTHY P PADERA', 18)}}的其他基金

Targeting lymph node metastases to block cancer progression
针对淋巴结转移阻止癌症进展
  • 批准号:
    10743193
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
Reversing aging-induced lymphatic dysfunction to improve immune function
逆转衰老引起的淋巴功能障碍,改善免疫功能
  • 批准号:
    10544735
  • 财政年份:
    2022
  • 资助金额:
    $ 24.86万
  • 项目类别:
2022 Lymphatics GRC and GRS
2022 淋巴 GRC 和 GRS
  • 批准号:
    10378787
  • 财政年份:
    2021
  • 资助金额:
    $ 24.86万
  • 项目类别:
Targeting lymph node metastases to prevent cancer progression
针对淋巴结转移预防癌症进展
  • 批准号:
    9286149
  • 财政年份:
    2017
  • 资助金额:
    $ 24.86万
  • 项目类别:
Targeting lymph node metastases to prevent cancer progression
针对淋巴结转移以预防癌症进展
  • 批准号:
    10542290
  • 财政年份:
    2017
  • 资助金额:
    $ 24.86万
  • 项目类别:
Characterization of lymphatic contraction during infection
感染期间淋巴收缩的特征
  • 批准号:
    8422972
  • 财政年份:
    2012
  • 资助金额:
    $ 24.86万
  • 项目类别:
Characterization of lymphatic contraction during infection
感染期间淋巴收缩的特征
  • 批准号:
    8225628
  • 财政年份:
    2012
  • 资助金额:
    $ 24.86万
  • 项目类别:
Characterizing lymphatic micrometastases: prognostic and therapeutic implications
淋巴微转移的特征:预后和治疗意义
  • 批准号:
    8146385
  • 财政年份:
    2011
  • 资助金额:
    $ 24.86万
  • 项目类别:
Lymphatic Radiobiology
淋巴放射生物学
  • 批准号:
    8326221
  • 财政年份:
    2008
  • 资助金额:
    $ 24.86万
  • 项目类别:
Lymphatic Radiobiology
淋巴放射生物学
  • 批准号:
    7686725
  • 财政年份:
    2008
  • 资助金额:
    $ 24.86万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了